BG104758A - Фармацевтични комбинации с трамадол - Google Patents

Фармацевтични комбинации с трамадол

Info

Publication number
BG104758A
BG104758A BG104758A BG10475800A BG104758A BG 104758 A BG104758 A BG 104758A BG 104758 A BG104758 A BG 104758A BG 10475800 A BG10475800 A BG 10475800A BG 104758 A BG104758 A BG 104758A
Authority
BG
Bulgaria
Prior art keywords
pharmaceutical combinations
combinations containing
migraine
pharmaceutically acceptable
treatment
Prior art date
Application number
BG104758A
Other languages
English (en)
Other versions
BG64888B1 (bg
Inventor
Marc Raber
Helmut Momberger
Original Assignee
VIATRIS Gmbh & Co.KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VIATRIS Gmbh & Co.KG filed Critical VIATRIS Gmbh & Co.KG
Publication of BG104758A publication Critical patent/BG104758A/bg
Publication of BG64888B1 publication Critical patent/BG64888B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретението се отнася до използването на фармацевтични комбинации, които съдържат като активно вещество трамадол или негови енантиомери, или неговафармацевтично приемлива сол и метоклопрамид, домперидон, или други прокинетично и антиеметично действащи вещества или тяхна фармацевтично приемлива сол, за лечение на мигрена и мигрениформено главоболие. Комбинациите се прилагат също за лечение на болестни състояния, които настъпват с гадене и/или повръщане, например при химиотерапия, и/или при забавено изпразване на стомаха.
BG104758A 1998-02-21 2000-09-12 Фармацевтични комбинации с трамадол BG64888B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19807535A DE19807535A1 (de) 1998-02-21 1998-02-21 Pharmazeutische Kombinationen mit Tramadol

Publications (2)

Publication Number Publication Date
BG104758A true BG104758A (bg) 2001-04-30
BG64888B1 BG64888B1 (bg) 2006-08-31

Family

ID=7858642

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104758A BG64888B1 (bg) 1998-02-21 2000-09-12 Фармацевтични комбинации с трамадол

Country Status (26)

Country Link
EP (1) EP1056448B1 (bg)
JP (1) JP2002503689A (bg)
KR (1) KR100567154B1 (bg)
CN (1) CN1141937C (bg)
AR (1) AR018102A1 (bg)
AT (1) ATE257700T1 (bg)
AU (1) AU748993B2 (bg)
BG (1) BG64888B1 (bg)
BR (1) BR9909211A (bg)
CZ (1) CZ291941B6 (bg)
DE (2) DE19807535A1 (bg)
DK (1) DK1056448T3 (bg)
EA (1) EA002166B1 (bg)
ES (1) ES2212549T3 (bg)
HK (1) HK1035143A1 (bg)
HU (1) HU225656B1 (bg)
IL (1) IL137505A (bg)
NO (1) NO327860B1 (bg)
NZ (1) NZ506020A (bg)
PL (1) PL204075B1 (bg)
PT (1) PT1056448E (bg)
SK (1) SK284937B6 (bg)
TR (1) TR200002411T2 (bg)
TW (1) TWI228040B (bg)
WO (1) WO1999042095A1 (bg)
ZA (1) ZA991212B (bg)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0104420A2 (en) * 1998-12-02 2002-08-28 Darwin Discovery Ltd Therapeutic composition containing a new form of tramadol and its use
DE19940944B4 (de) * 1999-08-31 2006-10-12 Grünenthal GmbH Retardierte, orale, pharmazeutische Darreichungsformen
WO2001064202A2 (en) * 2000-03-01 2001-09-07 Euro-Celtique S.A. Tramadol for the treatment of functional gastrointestinal disorders
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
DE10108122A1 (de) 2001-02-21 2002-10-02 Gruenenthal Gmbh Arzneimittel auf Basis von Tramadol
DE102004020220A1 (de) * 2004-04-22 2005-11-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
DE10361596A1 (de) * 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US7553858B2 (en) * 2003-12-17 2009-06-30 Meda Pharma Gmbh & Co. Kg Combination of flupirtine and tramadol
JP2010522135A (ja) 2006-10-09 2010-07-01 チャールストン ラボラトリーズ，インコーポレイテッド 医薬組成物
JP5714910B2 (ja) 2008-01-09 2015-05-07 チャールストン ラボラトリーズ，インコーポレイテッド 薬学的組成物
CA2722743A1 (en) 2008-04-28 2009-11-05 Zogenix, Inc. Novel formulations for treatment of migraine
US20130213393A1 (en) 2009-12-22 2013-08-22 Evoke Pharma, Inc. Nasal formulations of metoclopramide
CA2767576C (en) 2009-07-08 2020-03-10 Charleston Laboratories Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
WO2015157738A1 (en) * 2014-04-10 2015-10-15 Charleston Laboratories, Inc. Pharmaceutical compositions
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
WO2018112061A1 (en) * 2016-12-15 2018-06-21 Evoke Pharma, Inc. Treatment of moderate and severe gastroparesis
JP7195660B1 (ja) 2021-09-09 2022-12-26 壽製薬株式会社 口腔内崩壊錠

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU528098B2 (en) * 1978-11-16 1983-04-14 Beecham Group Plc Analgesic tablet
AU528310B2 (en) * 1978-11-16 1983-04-21 Beecham Group Plc Composition of paracetamol and metoclopramide
CA2020018A1 (en) * 1990-06-27 1991-12-28 Don L. Simmons Method and composition for treating the migraine complex
GB9214184D0 (en) * 1992-07-03 1992-08-12 Smithkline Beecham Plc Pharmaceuticals
FR2712809B1 (fr) * 1993-11-26 1996-04-12 Union Pharma Scient Appl Nouvelle composition pharmaceutique destinée à la préparation d'une poudre stable contenant, à titre d'ingrédient actif, une association d'acide acétylsalicylique et de métoclopramide.
FR2720936B1 (fr) * 1994-06-08 1997-04-30 Synthelabo Poudres à base de métoclopramide et de paracétamol ou de dérivés d'acide acétylsalicylique.
GB9523566D0 (en) * 1995-11-17 1996-01-17 Euro Celtique Sa Pharmaceutical formulation
FR2741532B1 (fr) * 1995-11-28 1998-08-21 Bouchara Sa Nouvelles compositions pharmaceutiques a action antimigraineuse et leur mode de preparation
GB2313309B (en) * 1996-05-24 2000-01-26 Ninh Thuy On Pharmaceutical compositions comprising a nonsteroidal anti-inflammatory drug and domperidone in the treatment of migraine

Also Published As

Publication number Publication date
KR100567154B1 (ko) 2006-04-04
SK12172000A3 (sk) 2001-04-09
IL137505A (en) 2005-07-25
PL204075B1 (pl) 2009-12-31
CN1291092A (zh) 2001-04-11
HU225656B1 (en) 2007-05-29
ZA991212B (en) 1999-08-03
EA002166B1 (ru) 2001-12-24
DK1056448T3 (da) 2004-05-17
SK284937B6 (sk) 2006-02-02
PT1056448E (pt) 2004-05-31
AU3514899A (en) 1999-09-06
AR018102A1 (es) 2001-10-31
NO20004143D0 (no) 2000-08-18
EP1056448B1 (de) 2004-01-14
BG64888B1 (bg) 2006-08-31
HUP0100964A3 (en) 2003-09-29
HK1035143A1 (en) 2001-11-16
DE19807535A1 (de) 1999-08-26
IL137505A0 (en) 2001-07-24
ES2212549T3 (es) 2004-07-16
CN1141937C (zh) 2004-03-17
TWI228040B (en) 2005-02-21
BR9909211A (pt) 2000-11-14
PL342546A1 (en) 2001-06-18
EA200000862A1 (ru) 2001-02-26
WO1999042095A1 (de) 1999-08-26
EP1056448A1 (de) 2000-12-06
ATE257700T1 (de) 2004-01-15
NZ506020A (en) 2002-05-31
CZ20002939A3 (cs) 2000-12-13
AU748993B2 (en) 2002-06-13
KR20010041110A (ko) 2001-05-15
NO20004143L (no) 2000-09-27
TR200002411T2 (tr) 2000-12-21
CZ291941B6 (cs) 2003-06-18
JP2002503689A (ja) 2002-02-05
DE59908305D1 (de) 2004-02-19
HUP0100964A2 (hu) 2001-08-28
NO327860B1 (no) 2009-10-05

Similar Documents

Publication Publication Date Title
BG104758A (bg) Фармацевтични комбинации с трамадол
SI0725779T1 (bg)
GEP20043161B (en) Piperidines as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Modulators
CA2386690A1 (en) Pharmaceutical tramadol salts
MXPA03007712A (es) Sales farmaceuticas.
GB9104890D0 (en) Compositions
MXPA04004567A (es) Compuestos y composiciones de fenoxi amina para adminstrar agentes activos.
ZA972147B (en) Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical active ingredients.
ES8506615A1 (es) Un procedimiento para la preparacion de carboxamidas
WO1992019617A3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
ZA922297B (en) Crystalline tiababine monohydrate,its preparation and use
SI1121127T1 (en) Oral pharmaceutical compositions containing buprenorphin
TW324662B (en) Benzamide-containing pharmaceutical composition
IL152337A0 (en) A pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds
DE69120287D1 (en) Aminosulfonylharnstoff-acat-inhibitoren
HUT56556A (en) Process for producing new piperazinecarboxamides containing phenoxyalkyl or thiophenoxyalkyl side chain, as well as pharmaceutical compositions comprising such compounds as active ingredient
AP2000002017A0 (en) Salts of paroxetine.
ATE234096T1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
HUP9903880A3 (en) Naphtoquinone-derivatives, process for their preparation, fungicidal, insecticidal and acaricidal compositions, containing them as active ingredient and process for their use
MD457G2 (ro) Derivaţi noi de naftiridină, procedeu de preparare a lor, compoziţii farmaceutice care le conţin, utilizarea lor ca medicamente de antireproducere
ZA928127B (en) Use of substituted pyrrolidines, some of which are known, as medicaments, new active substances and processes for their preparation.
HUP0103623A3 (en) Bispiperidines as antithrombotic agents, their process for preparation and medicament containing them as active ingredient
HUT51641A (en) Process for producing pseudoprimycin and its components, as well as pharmaceutical compositions comprising such active ingredient
JO1843B1 (en) Benzimercool vehicles carry alternatives and processes for their preparation and use in a pharmacy
HUT52096A (en) Fungicides comprising 1-(aminomethyl)-3-(2,4-difluoro-3-chlorophenyl)-4-cyanopyrrole derivatives as active ingredient and process for producing the active ingredients